TY - JOUR
T1 - Management of acute pulmonary embolism with sequential hybrid therapy of surgical thrombectomy and rivaroxaban intensive therapy
T2 - A case report
AU - Migita, Shohei
AU - Murata, Nobuhiro
AU - Fukamachi, Daisuke
AU - Fukumoto, Katsunori
AU - Arai, Riku
AU - Uchiyama, Hiroe
AU - Tago, Kenichiro
AU - Okada, Masahiro
AU - Tanaka, Masashi
AU - Okumura, Yasuo
N1 - Publisher Copyright:
©The Author(s) 2023. Published by Oxford University Press. All rights reserved.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Acute pulmonary embolism (PE) is often associated with rapid hemodynamic deterioration or death. Therefore, early therapeutic intervention is important. A 45-year-old man was diagnosed with intermediate-high risk PE, and sequential hybrid therapy consisting of surgical thrombectomy and rivaroxaban intensive therapy was administered. During the course of treatment, echocardiography revealed improvement in pulmonary artery systolic pressure, and thrombus volume analysis by computed tomography revealed a drastic reduction in the size of the thrombus. Sequential hybrid therapy for acute PE not only stabilizes hemodynamics, but may also prevent conversion to chronic thromboembolic pulmonary hypertension by sufficiently reducing the volume of the thrombus.
AB - Acute pulmonary embolism (PE) is often associated with rapid hemodynamic deterioration or death. Therefore, early therapeutic intervention is important. A 45-year-old man was diagnosed with intermediate-high risk PE, and sequential hybrid therapy consisting of surgical thrombectomy and rivaroxaban intensive therapy was administered. During the course of treatment, echocardiography revealed improvement in pulmonary artery systolic pressure, and thrombus volume analysis by computed tomography revealed a drastic reduction in the size of the thrombus. Sequential hybrid therapy for acute PE not only stabilizes hemodynamics, but may also prevent conversion to chronic thromboembolic pulmonary hypertension by sufficiently reducing the volume of the thrombus.
UR - http://www.scopus.com/inward/record.url?scp=85160620976&partnerID=8YFLogxK
U2 - 10.1093/omcr/omad033
DO - 10.1093/omcr/omad033
M3 - Article
AN - SCOPUS:85160620976
SN - 2053-8855
VL - 2023
JO - Oxford Medical Case Reports
JF - Oxford Medical Case Reports
IS - 4
M1 - omad033
ER -